Differences in Patient Characteristics and Midterm Outcome Between Asian and European Patients Treated with Radiofrequency Ablation for Hepatocellular Carcinoma

• Main Authors: Burgmans, M.C, Too, C.W, Fiocco, M, Kerbert, A.J.C, Lo, R.H.G, Schaapman, J.J, van Erkel, A.R, Coenraad, M.J, Tan, B.S
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: Springer New York LLC 2020
• Subjects: sorafenib; adult; aged; Article; Asian; cancer incidence; cancer prognosis; cancer recurrence; cancer size; cancer survival; cause specific survival; chemoembolization; European; female; follow up; hepatitis B; hepatitis C; human; liver cell carcinoma; liver resection; liver transplantation; major clinical study; male; middle aged; overall survival; priority journal; race difference; radioembolization; radiofrequency ablation; radiofrequency ablation device; retrospective study; treatment outcome; age; Asian continental ancestry group; Carcinoma, Hepatocellular; catheter ablation; Caucasian; causality; comorbidity; incidence; Liver Cirrhosis, Alcoholic; Liver Neoplasms; procedures; statistics and numerical data; tumor recurrence; Age Factors; Aged; Asian Continental Ancestry Group; Catheter Ablation; Causality; Comorbidity; European Continental Ancestry Group; Female; Follow-Up Studies; Hepatitis B; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179275
• Institution: National University of Singapore

10.1007/s00270-016-1462-7